Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to describe the patient population being treated and evaluate their treatment adherence and treatment outcomes during treatment of scalp psoriasis with Daivobet® gel Applicator for 4 weeks.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| calcipotriol/betamethasone dipropionate gel in Applicator | Drug | Topical treatment of scalp using applicator device. The study as such is non-interventional as the intervention has been decided prior to and independently from the inclusion of the patient in the cohort to be observed. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Morisky Medication Adherence Scale-8 | Degree of adherence to prescribed treatment | 2 weeks |
| Morisky Medication Adherence Scale-8 | Degree of adherence to prescribed treatment | 4 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Patient opinion on Applicator usability | 5-point Likert scale | 4 weeks |
| Patient overall satisfaction | 4 point Likert scale | 4 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Adult patients with psoriasis vulgaris affecting the scalp who are prescribed scalp treatment with Daivobet® gel Applicator.
Representativeness is ensured through random sampling of investigators to be invited to participate from a country wide list of dermatologists and general practitioners, with adjustment for regional distribution. Investigators include their first three patients meeting the study criteria.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mathilde Kemula, MD | Cabinet de Dermatologie, Dr. Mathilde Kemula | Principal Investigator |
| Frederic Bonnier, MD | General Practice, 356 Rue de Charles de Gaulle, 91400 Orsay | Principal Investigator |
| Nathalie Quiles, MD | Hôpital Saint Joseph, 26 Boulevard de Louvain, Marseille | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cabinet de Dermatologie, Dr. Mathilde Kemula | Charenton-le-Pont | 94220 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 3945130 | Background | Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986 Jan;24(1):67-74. doi: 10.1097/00005650-198601000-00007. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| C055085 | calcipotriene |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Patient Global Impression of Improvement | 7 point Likert scale | 2 weeks |
| Patient Global Impression of Improvement | 7 point Likert scale | 4 weeks |
| Investigator's opinion on the properties of the Applicator | 5 point rating scale | Baseline |